Trending: Moderna Touts New Booster's Effectiveness Against Covid Variants
November 14 2022 - 2:20PM
Dow Jones News
13:50 ET -- Moderna Inc. is one of the most talked about
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. The pharmaceutical company said Monday
that its updated Covid-19 booster worked against Omicron
subvariants BA.4 and BA.5 better than its previous vaccine. Chief
Executive Stephane Bancel said that the boosters show neutralizing
activity against this increasingly dominant emerging variant,
"confirming that updated vaccines have the potential to offer
protection as the virus continues to evolve rapidly to escape our
immunity." Moderna shares were recently up about 6.2%, at $181.73.
Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)
(END) Dow Jones Newswires
November 14, 2022 14:05 ET (19:05 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024